LYPLA1 and non-small cell lung carcinoma: Mohammed et al. found that inhibition of LYPLA1 gene expression restrained cell proliferation, migration and invasion in vitro of non-small cell lung cancer (NSCLC) cell lines, suggesting that LYPLA1 might be an effective therapeutic target for NSCLC cancer therapy [63].